Stock Research for BCLI

BCLI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BCLI Stock Chart & Research Data

The BCLI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BCLI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BCLI Due diligence Resources & Stock Charts

The BCLI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BCLI Detailed Price Forecast - CNN Money CNN View BCLI Detailed Summary - Google Finance
Yahoo View BCLI Detailed Summary - Yahoo! Finance Zacks View BCLI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BCLI Trends & Analysis - Trade-Ideas Barrons View BCLI Major Holders - Barrons
NASDAQ View BCLI Call Transcripts - NASDAQ Seeking View BCLI Breaking News & Analysis - Seeking Alpha
Spotlight View BCLI Annual Report - CompanySpotlight.com OTC Report View BCLI OTC Short Report - OTCShortReport.com
TradeKing View BCLI Fundamentals - TradeKing Charts View BCLI SEC Filings - Bar Chart
WSJ View Historical Prices for BCLI - The WSJ Morningstar View Performance/Total Return for BCLI - Morningstar
MarketWatch View the Analyst Estimates for BCLI - MarketWatch CNBC View the Earnings History for BCLI - CNBC
StockMarketWatch View the BCLI Earnings - StockMarketWatch MacroAxis View BCLI Buy or Sell Recommendations - MacroAxis
Bullish View the BCLI Bullish Patterns - American Bulls Short Pains View BCLI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BCLI Stock Mentions - StockTwits PennyStocks View BCLI Stock Mentions - PennyStockTweets
Twitter View BCLI Stock Mentions - Twitter Invest Hub View BCLI Investment Forum News - Investor Hub
Yahoo View BCLI Stock Mentions - Yahoo! Message Board Seeking Alpha View BCLI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BCLI - SECform4.com Insider Cow View Insider Transactions for BCLI - Insider Cow
CNBC View BCLI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BCLI - OTC Markets
Yahoo View Insider Transactions for BCLI - Yahoo! Finance NASDAQ View Institutional Holdings for BCLI - NASDAQ


Stock Charts

FinViz View BCLI Stock Insight & Charts - FinViz.com StockCharts View BCLI Investment Charts - StockCharts.com
BarChart View BCLI Stock Overview & Charts - BarChart Trading View View BCLI User Generated Charts - Trading View




Latest Financial News for BCLI


BrainStorm Announces Grant of a New European Patent for NurOwn®
Posted on Wednesday July 25, 2018

NEW YORK and PETACH TIKVAH, Israel, July  25, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, ...


BCLI: Phase 3 Trial in ALS Fully Funded; Company to Announced Additional Indications for NurOwn
Posted on Tuesday July 24, 2018

On July 23, 2018, BrainStorm Cell Therapeutics, Inc. (BCLI) announced financial results for the second quarter of 2018 and provided a business update. As expected, the company did not report any revenues for the quarter. The company recorded R&D expenses for the second quarter of 2017 and 2018 net of research and development grants from the Israel Innovation Authority (IIA, formerly the Office of the Chief Scientist) and the California Institute for Regenerative Medicine (CIRM).


BrainStorm Announces Financial Results for the Second Quarter of 2018 and Provides a Corporate Update
Posted on Monday July 23, 2018

Conference Call and Webcast at 8.30am ET Today NEW YORK and PETACH TIKVAH, Israel , July 23, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell ...


Brainstorm Cell Therapeutics Inc. to Host Earnings Call
Posted on Monday July 23, 2018

NEW YORK, NY / ACCESSWIRE / July 23, 2018 / Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 23, 2018 at 8:30 AM ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.